Association analysis of the -308G>A promoter polymorphism of the tumor necrosis factor alpha (TNF-alpha) gene in Japanese patients with schizophrenia. 2004

R Hashimoto, and M Yoshida, and N Ozaki, and Y Yamanouchi, and N Iwata, and T Suzuki, and T Kitajima, and M Tatsumi, and K Kamijima, and H Kunugi
Department of Mental Disorder Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan. rhashimo@ncnp.go.jp

Two research groups have thus far reported a significant association between schizophrenia and a promoter polymorphism (-308G > A) of the gene encoding tumor necrosis factor alpha (TNF-alpha), while contradictive negative results have also been reported. We examined the possible association in a Japanese sample of 297 schizophrenia cases and 458 controls. Allele frequencies of both the patients and controls were very low (1.5% and 0.8%, respectively), and the difference was not statistically significant. We conclude that the effect of the -308G > A polymorphism on the development of schizophrenia is, if any, weak and the majority of Japanese schizophrenics are unrelated to the -308G > A polymorphism of the TNF-alpha gene.

UI MeSH Term Description Entries
D007564 Japan A country in eastern Asia, island chain between the North Pacific Ocean and the Sea of Japan, east of the Korean Peninsula. The capital is Tokyo. Bonin Islands
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011110 Polymorphism, Genetic The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level. Gene Polymorphism,Genetic Polymorphism,Polymorphism (Genetics),Genetic Polymorphisms,Gene Polymorphisms,Polymorphism, Gene,Polymorphisms (Genetics),Polymorphisms, Gene,Polymorphisms, Genetic
D011401 Promoter Regions, Genetic DNA sequences which are recognized (directly or indirectly) and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved sequences within the promoter include the Pribnow box in bacteria and the TATA BOX in eukaryotes. rRNA Promoter,Early Promoters, Genetic,Late Promoters, Genetic,Middle Promoters, Genetic,Promoter Regions,Promoter, Genetic,Promotor Regions,Promotor, Genetic,Pseudopromoter, Genetic,Early Promoter, Genetic,Genetic Late Promoter,Genetic Middle Promoters,Genetic Promoter,Genetic Promoter Region,Genetic Promoter Regions,Genetic Promoters,Genetic Promotor,Genetic Promotors,Genetic Pseudopromoter,Genetic Pseudopromoters,Late Promoter, Genetic,Middle Promoter, Genetic,Promoter Region,Promoter Region, Genetic,Promoter, Genetic Early,Promoter, rRNA,Promoters, Genetic,Promoters, Genetic Middle,Promoters, rRNA,Promotor Region,Promotors, Genetic,Pseudopromoters, Genetic,Region, Genetic Promoter,Region, Promoter,Region, Promotor,Regions, Genetic Promoter,Regions, Promoter,Regions, Promotor,rRNA Promoters
D005260 Female Females
D005787 Gene Frequency The proportion of one particular in the total of all ALLELES for one genetic locus in a breeding POPULATION. Allele Frequency,Genetic Equilibrium,Equilibrium, Genetic,Allele Frequencies,Frequencies, Allele,Frequencies, Gene,Frequency, Allele,Frequency, Gene,Gene Frequencies
D006147 Guanine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000225 Adenine A purine base and a fundamental unit of ADENINE NUCLEOTIDES. Vitamin B 4,4, Vitamin B,B 4, Vitamin

Related Publications

R Hashimoto, and M Yoshida, and N Ozaki, and Y Yamanouchi, and N Iwata, and T Suzuki, and T Kitajima, and M Tatsumi, and K Kamijima, and H Kunugi
June 2019, Genetic testing and molecular biomarkers,
R Hashimoto, and M Yoshida, and N Ozaki, and Y Yamanouchi, and N Iwata, and T Suzuki, and T Kitajima, and M Tatsumi, and K Kamijima, and H Kunugi
May 2012, International journal of dermatology,
R Hashimoto, and M Yoshida, and N Ozaki, and Y Yamanouchi, and N Iwata, and T Suzuki, and T Kitajima, and M Tatsumi, and K Kamijima, and H Kunugi
February 2021, Scientific reports,
R Hashimoto, and M Yoshida, and N Ozaki, and Y Yamanouchi, and N Iwata, and T Suzuki, and T Kitajima, and M Tatsumi, and K Kamijima, and H Kunugi
April 2021, Neurological research,
R Hashimoto, and M Yoshida, and N Ozaki, and Y Yamanouchi, and N Iwata, and T Suzuki, and T Kitajima, and M Tatsumi, and K Kamijima, and H Kunugi
January 1995, Journal of inflammation,
R Hashimoto, and M Yoshida, and N Ozaki, and Y Yamanouchi, and N Iwata, and T Suzuki, and T Kitajima, and M Tatsumi, and K Kamijima, and H Kunugi
January 2008, Neuropsychobiology,
R Hashimoto, and M Yoshida, and N Ozaki, and Y Yamanouchi, and N Iwata, and T Suzuki, and T Kitajima, and M Tatsumi, and K Kamijima, and H Kunugi
December 2003, Schizophrenia research,
R Hashimoto, and M Yoshida, and N Ozaki, and Y Yamanouchi, and N Iwata, and T Suzuki, and T Kitajima, and M Tatsumi, and K Kamijima, and H Kunugi
August 1999, Tissue antigens,
R Hashimoto, and M Yoshida, and N Ozaki, and Y Yamanouchi, and N Iwata, and T Suzuki, and T Kitajima, and M Tatsumi, and K Kamijima, and H Kunugi
January 2016, Journal of human reproductive sciences,
R Hashimoto, and M Yoshida, and N Ozaki, and Y Yamanouchi, and N Iwata, and T Suzuki, and T Kitajima, and M Tatsumi, and K Kamijima, and H Kunugi
September 2007, Psychiatry research,
Copied contents to your clipboard!